JUAN ESPINOSA PACC: Open Payments
NPI 1750381026 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,625 in 113 payments from 13 companies in 2025. Trend: 2023 $82,357 · 2024 $46,601 · 2025 $41,625
Speaker / faculty: $28,635Consulting: $7,660Food & beverage: $4,149Travel & lodging: $1,180
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $17,044 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $14,256 |
| ABBVIE INC. | 7 | $4,728 |
| E.R. Squibb & Sons, L.L.C. | 13 | $3,785 |
| Teva Pharmaceuticals USA, Inc. | 15 | $706 |
| Otsuka America Pharmaceutical, Inc. | 7 | $388 |
| Almatica Pharma LLC | 8 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $135 |
| Novo Nordisk Inc | 1 | $121 |
| Alkermes, Inc. | 5 | $115 |
Products named: FANAPT, CAPLYTA, VRAYLAR, COBENFY, REXULTI, AUSTEDO XR, UZEDY, LOREEV XR.
Industry payments across FL — which companies pay providers there.
